Research output per year
Research output per year
Personal profile
Qualifications
2021: Doctor of Philosophy (PhD) currently studying, The University of Manchester
2021: Registration with General Pharmaceutical Council
2020: Provisional registration with General Pharmaceutical Council
2019: Master of Pharmacy (MPharm), The University of Manchester
Research interests
- Mental health patient safety - primary and secondary care
- Psychotropic medication use and safety
- Appropriate prescribing and monitoring of psychotropics
- Medication errors (prescribing, monitoring, dispensing, and administration)
- Adverse drug events
- Epidemiology and aetiology of medication safety issues for patients with mental illness
Memberships of committees and professional bodies
Registered General Pharmaceutical Council (GPhC)
Member Royal Pharmaceutical Society (RPS)
Associate Member College of Mental Health Pharmacy (CMHP)
Member British Association for Psychopharmacology (BAP)
Pharmacist's Defence Association (PDA)
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Master of Pharmacy, MPharm
21 Sep 2015 → 25 Jun 2019
Award Date: 25 Jun 2019
Areas of expertise
- RM Therapeutics. Pharmacology
- RS Pharmacy and materia medica
Fingerprint
Dive into the research topics where Matthew Ayre is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 1 Conference contribution
-
Understanding the medication safety issues for patients with mental illness in primary care: a scoping review
Ayre, M., Lewis, P. & Keers, R., 9 Aug 2022, Society for Academic Primary Care. 1 ed. Oxford, Vol. 1. p. 90-91 223 p.Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review
Open Access